Barclays analyst Emily Field raised the firm’s price target on Argenx to EUR 450 from EUR 405 and keeps an Overweight rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ARGX:
- Argenx to acquire PRV for $102M
- argenx Enters Into Agreement To Acquire Priority Review Voucher
- argenx Announces U.S. FDA Acceptance of Biologics License Application for Subcutaneous Efgartigimod in Generalized Myasthenia Gravis with Priority Review
- Argenx price target raised to EUR 480 from EUR 470 at JPMorgan
- argenx to Present at Upcoming Investor Conferences
